Clinical trial
AZMATICS: AZithroMycin/Asthma Trial In Community Settings
NCT00266851 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00266851 |
|---|---|
| Title | AZMATICS: AZithroMycin/Asthma Trial In Community Settings |
| Official title | AZMATICS: Azithromycin Asthma Trial In Community Settings |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | American Academy of Family Physicians Dean Foundation Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Azithromycin, Placebo |
| Enrollment | 97 |
| Start date | Jan 1, 2006 |
| Primary completion | Nov 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Dec 19, 2005 |
| Last update posted | Sep 6, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: